🔉 Did tinnitus loudness improve?
Limited.
2022 meta-analysis: significant loudness reduction only with lateral-temporal stimulation, small-to-moderate effect.
tDCS / tACS / tRNS (transcranial electrical stimulation) for Tinnitus: What Does the Evidence Show?
Brain Stimulation
Current evidence
Low-cost and generally well tolerated in trials, possibly a mild adjunct — the evidence is too heterogeneous to say more.
Evidence strength: Limited (2/5) · Tier 3 — experimental/emerging · Evidence independence: Primarily independent.
Weak electrical currents applied to the scalp (direct, alternating, or random-noise), in clinic or via emerging home-use protocols. tRNS has only small pilot studies (a 2024 systematic review of 7 calls it 'promising' but unproven). At the invasive extreme, deep brain stimulation for tinnitus exists only as tiny case series (a caudate Phase 1 of 6 patients) and a 7-patient Grenoble trial.
Did tinnitus loudness or distress improve?
🧠 Did tinnitus distress improve?
Limited.
2022 meta-analysis of tDCS (14 studies, 1,031 people): tinnitus distress fell overall (SMD −0.50, 95% CI −0.91 to −0.10), but there was no significant effect on psychiatric symptoms such as depression or anxiety. Protocols varied and studies were small; verdict — possible adjunct, not standalone.
Loudness means the tinnitus percept itself became quieter (psychoacoustic matching or loudness ratings). Distress means questionnaire scores such as THI/TFI, sleep, anxiety or quality of life improved — the sound may be unchanged. A THI/TFI improvement is never evidence the tinnitus got quieter.
How strong is the evidence?
Small effects in heterogeneous trials: 2/5.
What the studies found 1 tracked
Transcranial electrical stimulation for tinnitus: meta-analysis
Martins ML, et al. · Neurophysiologie Clinique · 2022 · N=14 studies, N=1,031 (tDCS) · Meta-analysis (tDCS studies)
Small-to-moderate effects on tinnitus measures; overall pooled loudness effect significant (SMD −0.35); subgroup analysis localizes the benefit to lateral-temporal-area stimulation. No significant effect of treatment on psychiatric (depression/anxiety) symptoms. Verdict: possible adjunct, not a standalone treatment.
What are the limitations?
- Protocol heterogeneity blocks conclusions
- No durable-benefit evidence
- The pooled results cover tDCS only; they do not cover tACS or tRNS
Has the result been independently replicated?
Conflicting results. Independent trials and metas disagree by protocol/site; no consistent reproducible effect.
What should patients know about safety?
Safety evidence: Strong. Mild effects such as skin tingling at standard trial settings; the safety of other devices or settings is not established.
Is it available?
Regulatory status: Investigational for tinnitus. No FDA authorization for tinnitus.
Availability: Research settings · Europe: Research (UK WHITBY home-tDCS feasibility trial running) · Cost (approx.): Low per-session cost in research; consumer devices unproven
Related clinical trials 1
- WHITBY: home-based tDCS feasibility — Recruiting
Tracked trials are research in progress, not recommended treatments.
Related treatments 2
- rTMS (repetitive transcranial magnetic stimulation) — Statistically real but clinically small — and whether any benefit lasts to 6 months is disputed between the…
- Transcranial focused ultrasound (emerging) — Focused ultrasound can reach deep brain circuits no coil can — first tinnitus study starting at Oxford; no…
Evidence last reviewed: 2026-09-04 · Evidence included through: 2026-09-04 · Confidence: moderate. Open the interactive evidence profile · How we rate evidence.
This page summarizes published research for education. It is not medical advice; it cannot say what will work for any individual. Discuss treatment decisions with a qualified clinician.